PricewaterhouseCoopers

Lion Biotechnologies names Molly Henderson chief financial officer

Monday, June 8, 2015 11:13 AM

Lion Biotechnologies, a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), has appointed Molly Henderson, CPA, as chief financial officer, effective immediately.

More... »


Mylan to commence formal offer to acquire Perrigo

Friday, April 24, 2015 01:21 PM

On April 8, Mylan issued a Rule 2.4 announcement under the Irish Takeover Rules stating that it had made a non-binding proposal to acquire Perrigo for $205 in a combination of cash and Mylan stock for each Perrigo share. The Rule 2.4 announcement followed the delivery of that proposal to Perrigo's chairman on April 6.

More... »


CRL announces planned management changes

Wednesday, March 4, 2015 08:50 AM

Massachusetts-based Charles River Laboratories International has announced planned management changes to be implemented over the course of 2015.

More... »

Viropro plans for restructuring following facility seizure

Wednesday, February 4, 2015 01:23 PM

Viropro, an integrated developer and manufacturer of biopharmaceutical products based in San Jose, Calif., has announced that its board of directors completed its strategic review and has begun the implementation of a restructuring designed to restore the company to financial health. 

More... »

Report: regulatory innovation should adapt to new health economy

Wednesday, January 28, 2015 01:25 PM

Consumers and drug and device manufacturers are changing practices and shifting attitudes toward the FDA.

More... »

Report: Total VC investment in second quarter highest since 2000

Friday, August 29, 2014 10:30 AM

Venture capitalists invested $13 billion in 1,114 deals in the second quarter of 2014, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters.

More... »

Bellerophon Therapeutics names Jonathan Peacock chairman and CEO

Wednesday, July 2, 2014 11:37 AM

Bellerophon Therapeutics, a clinical stage biotherapeutics company, has announced that Jonathan Peacock has been appointed chairman and CEO. Peacock assumes the role from Daniel Tasse, chairman and CEO of Ikaria, who was interim chairman and CEO of Bellerophon since the company's spin-out from Ikaria in February. Tasse will continue as a member of the board of Bellerophon.

More... »

Report: Value of U.S. health services M&A deals up 152%

Wednesday, May 21, 2014 01:29 PM

U.S. health services M&A total deal value rose 152% to $12.3 billion during the first quarter of 2014 compared to the same period in 2013, according to an analysis of M&A trends and outlook for the health services sector issued by PricewaterhouseCoopers U.S.

More... »

Report: Total VC investment in Q1 2014 highest since 2001

Monday, April 21, 2014 02:34 PM

Venture capitalists invested $9.5 billion in 951 deals in the first quarter of 2014, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters

More... »

Report: Venture capital in life sciences sector trailing other industries

Wednesday, February 19, 2014 01:14 PM

Venture capital funding for the life sciences sector, which includes biotechnology and medical devices, declined in 2013 by 1% in dollars invested and 3% in number of deals, compared to 2012, according to a new PwC U.S. report, Medtech Slowdown, which includes data from the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters

More... »


CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs